Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

CFO and Treasurer

Chief Scientific Officer

President and COO

Chief Executive Officer

Fulgent Genetics, Inc., together with its subsidiaries, provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology; oncology tests and testing services; and next generation sequencer services related to hereditary cancer, cardiovascular genetics, reproductive health, and neurodegenerative genetics, as well as pharmacogenetic tests. Its therapeutic development solutions focus on developing drug candidates for treating a range of cancers using a novel nanoencapsulation and targeted therapy platform designed to enhance the therapeutic window and pharmacokinetic profile, or PK profile, of new and existing cancer drugs. The company also operates picture genetics platform which includes proprietary gene probes, data suppression and comparison algorithms, adaptive learning software, and proprietary laboratory information management systems that helps customers to identify health markers in their personal DNA. It serves insurance, hospitals, medical institutions, other laboratories, governmental bodies, payors, municipalities and large corporations, and patients. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in Temple City, California.

Fulgent Genetics, Inc., together with its subsidiaries, provides clinical diagnostic and therapeutic development solutions to physicians a...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-03-01	Premium	sold (taxes)	Premium	Premium	Premium	CFO and Treasurer
2024-03-01	Premium	sold (taxes)	Premium	Premium	Premium	Chief Scientific Officer
2024-03-01	Premium	sold (taxes)	Premium	Premium	Premium	President and COO
2024-02-26	Premium	acquired	Premium	Premium	Premium	President and COO
2024-02-26	Premium	sold (taxes)	Premium	Premium	Premium	President and COO
2024-02-26	Premium	sold (taxes)	Premium	Premium	Premium	Chief Executive Officer
2024-02-26	Premium	acquired	Premium	Premium	Premium	CFO and Treasurer
2024-02-26	Premium	acquired	Premium	Premium	Premium	Chief Executive Officer
2024-02-26	Premium	sold (taxes)	Premium	Premium	Premium	Chief Scientific Officer
2024-02-26	Premium	acquired	Premium	Premium	Premium	Chief Scientific Officer
2024-02-26	Premium	sold (taxes)	Premium	Premium	Premium	CFO and Treasurer
2024-02-23	Premium	sold (taxes)	Premium	Premium	Premium	Chief Executive Officer
2024-02-23	Premium	sold (taxes)	Premium	Premium	Premium	CFO and Treasurer
2024-02-23	Premium	sold (taxes)	Premium	Premium	Premium	President and COO
2024-02-23	Premium	sold (taxes)	Premium	Premium	Premium	Chief Scientific Officer
2024-02-03	Premium	sold (taxes)	Premium	Premium	Premium	CFO and Treasurer
2024-02-03	Premium	sold (taxes)	Premium	Premium	Premium	President and COO
2024-02-01	Premium	sold (taxes)	Premium	Premium	Premium	Chief Executive Officer
2024-01-30	Premium	sold (taxes)	Premium	Premium	Premium	Chief Scientific Officer
2024-01-26	Premium	sold (taxes)	Premium	Premium	Premium	CFO and Treasurer
2024-01-26	Premium	sold (taxes)	Premium	Premium	Premium	President and COO
2024-01-26	Premium	sold (taxes)	Premium	Premium	Premium	Chief Scientific Officer
2023-12-11	Premium	sold	Premium	Premium	Premium	President and COO
2023-12-04	Premium	sold	Premium	Premium	Premium	Chief Scientific Officer
2023-12-04	Premium	sold	Premium	Premium	Premium	CFO and Treasurer

FLGT - Fulgent Genetics Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for FLGT